SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)

ABSTRACT: This study will be looking at whether CY/GVAX in combination with SGI-110 is effective (recruits CD45RO+ T cells to the tumor which may be a marker of anti-tumor activity) and safe in patients with metastatic colon or rectum cancers.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms,Neoplasms

PROVIDER: 2153426 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR